Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BMS-582949 in Rheumatoid Arthritis with Inadequate Response to Methotrexate
NCT00605735Phase 2Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Mar 2008
- Primary completion
- Aug 2009
- Modality
- Small Molecules
- Countries
- 8
01
Overview
Phase 2, randomised, double-blind trial of BMS-582949 in rheumatoid arthritis (RA), sponsored by Bristol Myers Squibb. Started Mar 2008; status: completed.
02
Drugs
BMS-582949
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00605735.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00605735.